Topic: Women’s Health

Women and heart disease
Feb 24 2015

Women and heart disease : An interview with cardiologist and author Nieca Goldberg, MD

Preventive Care  •  By Miles Varn

February is American Heart Month, so we talked with respected cardiologist and author Nieca Goldberg, MD. She shared her expert advice on the steps every woman should take to lower her risk of developing heart disease, the number one cause of death for women in the U.S. Dr. Goldberg is a nationally recognized pioneer in... Read More

new vaccine slows breast cancer
Jan 20 2015

New vaccine slows the progression of breast cancer in initial trial

Personalized Healthcare  •  By Miles Varn

For several decades, researchers have been working to develop vaccines that help the body’s own immune system to fight cancer. Recently, researchers at Washington University School of Medicine tested a breast cancer vaccine they developed and the results were encouraging, which may open a new avenue for women facing this disease. The new vaccine causes... Read More

Topics: ,
Genetic link to breast cancer
Dec 30 2014

Scientists uncover new genetic link to breast cancer. Are you at risk?

Personalized Healthcare  •  By Miles Varn

By the end of 2014, doctors in the U.S. will have diagnosed more than 232,000 new cases of breast cancer. For some women, this disease has a strong link to mutations in the BRCA genes. Now, a study published a few months ago in the New England Journal of Medicine uncovered a possible new relationship between... Read More

Topics: ,
Chemotherapy-induced hair loss
Dec 4 2014

Tips for managing hair loss during chemotherapy

Disease Management  •  By Miles Varn

While chemotherapy may be the most appropriate and effective treatment option for many breast cancer patients, like most treatments, it can cause side effects. Because chemotherapy drugs kill cells that quickly divide, which is how most tumor and cancer cells grow, they can also affect other healthy cells in the body that divide and grow... Read More

Topics: ,
Cancer patients and fertility
Nov 18 2014

5 questions cancer patients should ask about freezing their eggs or embryos

Personalized Healthcare  •  By Miles Varn

If you’re a women who’s about to undergo radiation or chemotherapy cancer treatment and you’re thinking about getting pregnant in the future, it’s important to talk to a doctor about options that can help protect your fertility before treatment starts. Two of the most common options are the freezing or banking of eggs or embryos.... Read More

Topics: ,
breast cancer diagnosis
Oct 30 2014

Were you diagnosed with breast cancer? Genetic testing may be crucial

Personalized Healthcare  •  By Miles Varn

By the end of 2014, doctors in the U.S. will have diagnosed more than 232,000 women and 2,300 men in the U.S. with breast cancer. Because October is Breast Cancer Awareness Month, this is an opportune time to discuss how pivotal genetic testing can be if you’ve been newly diagnosed with the malignancy. After you’re diagnosed, you... Read More

Topics: ,
Cardiovascular risks may be particularly high among female caregivers.
Jun 12 2014

Female caregivers shouldn’t overlook their own heart health

Family Caregiving  •  By Miles Varn

If you’re a woman caring for an ailing loved one, you can count yourself among the 44 million American adults who play this role. Caring for an ailing loved one can be a difficult and time-consuming job, and include a wide range of tasks, from helping them dress, eat and use the bathroom, to taking... Read More

doctor talking to his female patient at office
Apr 22 2014

Most women don’t know their stroke risk. Do you?

Disease Management  •  By Miles Varn

Every year, stroke kills more women than men. In fact, stroke kills twice as many women per year as breast cancer does, but 70 percent of women in a recent study published in the journal Stroke didn’t know that stroke was a significant health risk for them, weren’t aware of what factors increased their risk... Read More

Nov 12 2013

Pre-surgery drug may help women battle aggressive breast cancer

Disease Management  •  By Miles Varn

The U.S. Food and Drug Administration (FDA) recently granted fast track approval for the biologic, targeted cancer drug pertuzumab, known by the brand name PerjetaR, to treat HER2-positive breast cancer before surgery. The drug had previously been approved last year to treat late stage, HER2-positive breast cancer. Additional larger clinical trials to confirm the results... Read More

Topics: ,